http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2070799-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e05ecc55c1afdb18fa200bbf0bb4c642
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D335-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D335-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-382
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 1992-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78998a41216a3c9faf81a6e4c4d76162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03a2978c922052dc5e71b0169e511cc5
publicationDate 1992-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2070799-A1
titleOfInvention Thioxanthenone antitumor agents
abstract 1-[[(Dialkylamino)alkyl]amino]-4-substituted-thioxanthen-9-ones of the formula I (wherein n is 2 or 3; R1, R2 and R3 are lower alkyl; and R4 is hydrogen, lower alkyl, lower alkoxy or halogen) are disclosed as antitumor agents. Compositions containing the thioxanthenones and methods of treating tumors and cancer in mammals with the thioxanthenones are also disclosed.
priorityDate 1991-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414866734
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401

Total number of triples: 20.